Cardiovascular magnetic resonance of pulmonary artery growth and ventricular function after Norwood procedure with Sano modification by Lim, D Scott et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
Journal of Cardiovascular Magnetic 
Resonance
Open Access Research
Cardiovascular magnetic resonance of pulmonary artery growth 
and ventricular function after Norwood procedure with Sano 
modification
D Scott Lim*1, Benjamin B Peeler2, G Paul Matherne1 and 
Christopher M Kramer3
Address: 1Department of Pediatrics, University of Virginia, Charlottesville, USA, 2Department of Surgery, University of Virginia, Charlottesville, 
USA and 3Departments of Medicine & Radiology, University of Virginia, Charlottesville, USA
Email: D Scott Lim* - SL9PC@virginia.edu; Benjamin B Peeler - BBP2T@virginia.edu; G Paul Matherne - GPM2Y@virginia.edu; 
Christopher M Kramer - CMK2N@virginia.edu
* Corresponding author    
Abstract
For hypoplastic left heart syndrome (HLHS), there have been concerns regarding pulmonary artery
growth and ventricular dysfunction after first stage surgery consisting of the Norwood procedure
modified with a right ventricle-to-pulmonary artery conduit. We report our experience using
cardiovascular magnetic resonance (CMR) to determine and follow pulmonary arterial growth and
ventricular function in this cohort.
Following first stage palliation, serial CMR was performed at 1 and 10 weeks post-operatively,
followed by cardiac catheterization at 4 – 6 months. Thirty-four of 47 consecutive patients with
HLHS (or its variations) underwent first stage palliation. Serial CMR was performed in 20 patients.
Between studies, ejection fraction decreased (58 ± 9% vs. 50 ± 5%, p < 0.05). Pulmonary artery
growth occurred on the left (6 ± 1 mm vs. 4 ± 1 mm at baseline, p < 0.05) but not significantly in
the right. This trend continued to cardiac catheterization 4–6 months post surgery, with the left
pulmonary artery of greater size than the right (8.8 ± 2.2 mm vs. 6.7 +/- 1.9 mm, p < 0.05). By CMR,
5 had pulmonary artery stenoses initially, and at 2 months, 9 had stenoses. Three of the 9
underwent percutaneous intervention prior to the second stage procedure.
In this cohort, reasonable growth of pulmonary arteries occurred following first stage palliation
with this modification, although that growth was preferential to the left. Serial studies demonstrate
worsening of ventricular function for the cohort. CMR was instrumental for detecting pulmonary
artery stenosis and right ventricular dysfunction.
Background
Hypoplastic left heart syndrome is a congenital cardiac
malformation involving hypoplasia of the ascending
aorta, aortic valve atresia or stenosis, a hypoplastic left
ventricle, and mitral atresia or hypoplasia[1]. Until the
past few years, the standard surgical approach to hypo-
plastic left heart syndrome has either been a staged surgi-
cal palliation, with the first step being the modified
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Norwood procedure[2], or cardiac transplantation[3,4].
The first stage surgical palliation involves aortic arch aug-
mentation, atrial septectomy, and an aorto-pulmonary
shunt for pulmonary blood flow. While surgical survival
has improved at many institutions, the overall surgical
mortality of this first stage of palliation remains signifi-
cant[5,6]. Recently, a large number of institutions (includ-
ing the University of Virginia) have switched to the "Sano"
modification of the Norwood procedure, with improved
short-term results in some, but not all centers[7,8]. This
"Sano" modification of the Norwood procedure uses a
valveless right ventricle-to-pulmonary artery conduit in
place of the aorto-pulmonary shunt for pulmonary blood
flow. However, concern remains regarding the growth of
the pulmonary arteries and right ventricular function with
this surgical modification, which involves a ventriculot-
omy in the systemic right ventricle[9]. While echocardiog-
raphy has become the primary imaging modality in
pediatric cardiology, it is limited in its ability to image the
branch pulmonary arteries after this surgical intervention.
At the University of Virginia, because of these concerns it
became our clinical practice to perform a cardiovascular
magnetic resonance (CMR) study prior to discharge and at
two months of age, followed by cardiac catheterization at
4 – 6 months of age, in children with hypoplastic left heart
syndrome. The next stage of surgical palliation was usu-
ally performed after 4 – 6 months of age, and involved
ligation and division of the right ventricle-to-pulmonary
artery conduit, and creation of a superior vena cava-to-
pulmonary artery anastomosis. If CMR defined any signif-
icant pulmonary artery stenosis or coarctation, earlier
transcatheter intervention was undertaken.
The intent of this study was to report on the CMR assess-
ment of growth of the pulmonary arteries and right ven-
tricular function after the Norwood procedure with Sano
modification for hypoplastic left heart syndrome.
Methods
Approval for the study was obtained from the University
of Virginia Institutional Review Board Human Investiga-
tions Committee. We retrospectively reviewed the results
of all children admitted following birth to the University
of Virginia with the diagnosis of hypoplastic left heart syn-
drome (or its variations) from 2002 to the end of 2006.
The time period was chosen because in mid-2002 our
institution switched from the "standard" modified Nor-
wood procedure[2,10] to the Sano modification[8,11].
(Figure 1) The procedure was carried out with arterial can-
nulation via the innominate artery and regional perfusion
with minimal use of deep hyperthermic circulatory arrest.
The neoaortic arch was constructed utilizing pulmonary
homograft. The right ventricular to pulmonary artery con-
Left-sided drawing demonstrates surgical anatomy after Norwood procedure with Sano modification, in which pulmonary  blood flow is supplied by right ventricle-pulmonary artery conduit as labeled Figure 1
Left-sided drawing demonstrates surgical anatomy after Norwood procedure with Sano modification, in which 
pulmonary blood flow is supplied by right ventricle-pulmonary artery conduit as labeled. Right-sided CMR image 
shows site of coarctation repair and systemic right ventricle. (Drawing reprinted with permission from Scientific Software Solu-
tions, Inc.)Journal of Cardiovascular Magnetic Resonance 2008, 10:34 http://www.jcmr-online.com/content/10/1/34
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duit was constructed using either 5 or 6 mm ringed poly-
tetrafluoroethylene graft, running to the patient's right of
the neoaorta, and a chimney patch created and anastomo-
sed to the confluence of pulmonary arteries distally. The
chimney patch was constructed using a 0.4 mm thin pol-
ytetrafluoroethylene cardiovascular patch and the ringed
polytetrafluoroethylene conduit. The polytetrafluoroeth-
ylene patch was cut into an elliptical shape, and a 6 mm
hole was created in the center of the patch using an aortic
punch. The conduit was anastamosed to the opening in
the patch using a 6-0 prolene suture, and the chimney
patch was then anastamosed to the pulmonary artery con-
fluence. A 4.8 mm aortic punch was used to create a ven-
triculotomy in the right ventricular outflow tract. This
right ventriculotomy is used for the proximal anastomotic
site for the right ventricle-to-pulmonary artery conduit.
The conduit size was 5 mm in patients < 3.5 kg, and 6 mm
in the remainder. The same surgical and cardiology team
was involved in all cases.
Following an episode of unrecognized conduit and pul-
monary artery stenosis leading to cardiovascular collapse,
we began a clinical program of surveillance screening by
CMR for the development of significant pulmonary artery
stenosis or coarctation of the aorta. CMR was performed
in patients prior to discharge after first stage surgery, and
again at 2 months post-operatively. By prospective proto-
col, CMR was also performed at 1 year of age in patients
with persistent late ventricular dysfunction as defined by
follow-up echocardiography.
Studies were performed with general anesthesia and
endotracheal intubation, which allowed the patients to
remain still for the studies. Cardiac CMR was performed
on a 1.5 Tesla Sonata scanner (Siemens Medical Solu-
tions, Erlangen, Germany). The patient was placed supine
in a two-channel head coil with monitoring of electrocar-
diogram, blood pressure, and oxygen saturation. Steady
state free precession (SSFP) cine imaging was performed
with repetition time of 2.7 ms, echo time 1.3 ms, tempo-
ral resolution 19 ms, slice thickness 4 mm, flip angle 27°,
field of view 200 mm, matrix 76 × 192, and 4–5 signal
averages during free breathing. Spatial resolution for SSFP
was 2.6 × 1.0 × 4.0 mm. Axial and right ventricular short-
axis image stacks were obtained without a gap. In addi-
tion, velocity encoded gradient echo cine imaging was
obtained perpendicular to the proximal portion of the
right ventricle-to-pulmonary artery conduit and in the
plane of the proximal branch pulmonary arteries with rep-
etition time of 4 ms, echo time of 3.6 ms, temporal reso-
lution of 29 ms, slice thickness 4 mm, flip angle 30°, field
of view 200 mm, matrix 93 × 256, velocity encoded at 300
cm/s, and 3 signal averages during free breathing. Spatial
resolution for velocity encoded images was 2.2 × 0.8 × 4.0
mm. Finally, a 3-dimensional contrast-enhanced CMR
angiogram was obtained during infusion of 0.2 mM/kg of
gadolinium-DTPA. The angiogram was obtained in 1 slab
with repetition time of 3.75, echo time 1.4 ms, slice thick-
ness of 0.9 mm, flip angle 30°, field of view 200 mm,
matrix 75 × 320, and 6 signal averages. Spatial resolution
for CMR angiogram images was 2.7 × 0.6 × 0.9 mm.
Dedicated analysis software (Argus, Siemens Medical
Solutions, Malvern, PA) was utilized to calculate end-
diastolic ventricular volumes and systolic function from
the short axis SSFP cine images. The anterior-posterior
diameter of the branch pulmonary arteries was measured
from the velocity encoded cine images and confirmed by
the CMR angiogram, and the point of measurement was
at the hilum. SSFP cine images were not used for this
measurement because of off-resonance flow effects that
prevented adequate visualization of the branch pulmo-
nary arteries. Significant pulmonary artery stenosis or
coarctation were defined by CMR as an abrupt luminal
narrowing > 40%[12]. Right ventricle-to-pulmonary
artery conduit regurgitation volume and fraction was
measured from the velocity encoded imaging obtained
perpendicular to the conduit using Argus software. The
CMR angiogram was viewed on the Argus 3-dimensional
workstation as a multiplanar reformat and maximum
intensity projection.
At time of CMR, all patients also had transthoracic
echocardiography to compare estimates of ventricular
function, and diagnoses of pulmonary artery stenoses and
aortic coarctation. (Figure 2) Pulmonary artery stenosis
was diagnosed by demonstrating a qualitative luminal
narrowing on the color Doppler signal, rather than by
Doppler-derived gradients as there were high velocities
from the proximal conduit. Two-dimensional imaging by
echocardiography was not able to evaluate the branch
pulmonary artery anatomy after surgical palliation with
the right ventricle-pulmonary artery conduit. Echocardio-
graphic definition of coarctation was a peak-instantane-
ous Doppler-derived gradient in the aorta of > 20 mmHg
using both proximal and distal velocities in the complete
modified Bernoulli equation [13].
All patients underwent cardiac catheterization prior to the
second stage surgery, which was intended at 4–6 months
of age. Right ventricular ejection fraction was calculated
by calibrated biplane Simpson's rule [14]. Given the diffi-
culty with interpretation of multiple pressure gradients in
series, and that a large gradient is normally present across
the right ventricle-pulmonary artery conduit, only the
presence of a gradient at the site of angiographic luminal
narrowing in the branch pulmonary artery was used to
define a significant pulmonary artery stenosis. A signifi-
cant coarctation was defined by catheterization as a gradi-
ent of > 20 mmHg in the presence of angiographicJournal of Cardiovascular Magnetic Resonance 2008, 10:34 http://www.jcmr-online.com/content/10/1/34
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narrowing[15]. Significant coarctations underwent percu-
taneous balloon angioplasty[16,17], and success was
defined as a gradient of < 10 mmHg without significant
drop in cardiac output.
The authors had full access to the data and take responsi-
bility for its integrity. All authors have read and agree to
the manuscript as written.
Statistical Analysis
Serial measurements for patients were compared using
analysis of variance for repeated measures, and compari-
son between patients was analyzed using unpaired t tests,
with statistical significance defined as p < 0.05.
Results
Demographics
From 2002 to 2006, 47 newborns with hypoplastic left
heart syndrome (or its variations, see Table 1) were admit-
ted to the University of Virginia. Six patients received pal-
liative care only and expired shortly thereafter. Seven
patients with HLHS and high-risk features underwent
hybrid palliation, and have been previously reported on
by our group[18]. The remaining 34 patients underwent
the Norwood procedure with Sano modification at an age
of 9 +/- 8 days (range 1 – 47 days), with survival to hospi-
tal discharge in 26 of 34. Initially, the first 9 infants under-
went surgical intervention, and the 6 survivors were
followed without CMR screening. Following these first 9
patients, we then began the CMR screening program for
the reasons noted above. For the remainder of the study
period 25 infants underwent surgical palliation, of which
5 patients expired prior to hospital discharge, with cardiac
CMR being performed in the remaining 20 patients. There
were no complications from the anesthesia for the CMR
study.
CMR evaluation of the right ventricle
From the initial pre-discharge CMR study to the 2-month
study, right ventricular volumes increased (19 ± 6 mL vs.
32 ± 5 mL, p < 0.05) but were not different compared with
body growth (102 ± 33 mL/m2 vs. 105 ± 33 mL/m2, p =
NS), and right ventricular ejection fraction decreased
(58.0 ± 8.9% vs. 49.9 ± 5.4%, p < 0.05). (Figure 3) The
right ventricular ejection fraction as seen on the cardiac
catheterization prior to the 2nd stage surgical palliation
was 45 ± 9%. A comparison between echocardiographic
and CMR estimates of right ventricular function is shown
in Figure 4. There is overlap in CMR-determined right ven-
tricular ejection fraction between the different echocardi-
ographic classifications of ventricular function. The CMR-
determined right ventricular ejection fraction in the group
with "good" systolic function by echocardiography was 53
± 8%, with 25 ± 11% in the moderate group. The single
patient with an echocardiographic estimate of "poor"
function had an ejection fraction of 16%.
CMR evaluation of the branch pulmonary arteries
At time of initial CMR, the right and left pulmonary arter-
ies were of similar size (4.6 ± 0.9 mm vs. 4.4 ± 1.0 mm, p
= NS). However, pulmonary artery growth occurred
mainly in the left pulmonary artery (6.3 ± 1.1 mm vs.4.4
± 1.0 mm at baseline, p < 0.05), but not significantly in
the right (5.2 ± 1.5 mm vs. 4.6 ± 0.9 mm at baseline, p =
NS), with the left pulmonary artery larger at time of the
2nd CMR (6.3 ± 1.1 mm vs. 5.2 ± 1.5 mm for the right pul-
monary artery, p < 0.05). (Figures 5 &6) This trend
appeared to continue to the cardiac catheterization at 4 +/
- 1 months post surgery, with the left pulmonary artery of
significantly greater size than the right (8.8 ± 2.8 mm vs
6.7 ± 1.9 mm for the right pulmonary artery, p < 0.05).
By CMR, 5 patients had pulmonary artery stenoses
defined at the two-week study, and at the two-month
study 9/20 had pulmonary artery stenoses. Three of these
underwent early percutaneous intervention for severe uni-
lateral stenoses. On all 9 patients with CMR-defined pul-
monary artery stenosis, cardiac catheterization confirmed
the diagnosis. In those patients without CMR-defined pul-
monary artery stenosis, no significant pulmonary artery
stenosis was found at time of pre-operative cardiac cathe-
terization.
Panel A illustrates the difficulty in imaging the branch pulmo- nary arteries by transthoracic echocardiography Figure 2
Panel A illustrates the difficulty in imaging the 
branch pulmonary arteries by transthoracic echocar-
diography. Turbulence from the normally increased flow 
across the right ventricle-pulmonary artery conduit obscures 
the branch pulmonary artery anatomy. Panel B is in the same 
patient and branch pulmonary artery stenoses are demon-
strated clearly by CMR, which is confirmed at time of cardiac 
catheterization and angiography in panel C.
Table 1: Anatomic diagnoses of the cohort are listed.
Anatomic Diagnoses n
Hypoplastic left heart syndrome 30
Heterotaxy/Unbalanced AV canal with left ventricular hypoplasia 3
Double outlet right ventricle with left ventricular hypoplasia 1Journal of Cardiovascular Magnetic Resonance 2008, 10:34 http://www.jcmr-online.com/content/10/1/34
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However, the ability of echocardiography to diagnose
CMR-diagnosed pulmonary artery stenosis was poor, with
only a 6% sensitivity (1 of 18 stenoses were diagnosed by
echocardiography). There were no false positive diagnoses
of pulmonary artery stenosis by echocardiography.
There was no significant change in conduit regurgitant
fraction (15 ± 4% vs. 16 ± 5%) between studies.
CMR evaluation of the aortic coarctation
While 9 patients were defined by CMR at the 2-week study
as having a coarctation, clinically it was determined that
these did not require reintervention at that time. Among
these 9 patients, coarctations in 6 persisted or worsened
by the 2-month study, and resolved in 3. 2 additional
patients developed a significant coarctation that was
defined on the 2-month study. Ten of the 26 1st stage sur-
vivors underwent percutaneous coarctation intervention,
which was judged successful in 7, and one was felt not to
have clinical coarctation despite the CMR findings. This
was related to an artifact caused by a metal surgical clip.
Of the patients not diagnosed by CMR with a coarctation,
one was found to have a coarctation at time of the pre-
operative cardiac catheterization.
Echocardiography agreed with CMR-diagnosed coarcta-
tion in 7 of 10 patients who underwent cardiac catheteri-
zation. A single patient erroneously diagnosed with a
Growth of the left pulmonary artery is shown Figure 6
Growth of the left pulmonary artery is shown. There 
was significant growth between the first and second CMR 
studies.
Comparison between echocardiographic and cardiac mag- netic resonance imaging assessments of right ventricular  systolic function is shown Figure 4
Comparison between echocardiographic and cardiac 
magnetic resonance imaging assessments of right 
ventricular systolic function is shown.
Serial measurement of right ventricular ejection fraction is  shown, as assessed by cardiac CMR Figure 3
Serial measurement of right ventricular ejection 
fraction is shown, as assessed by cardiac CMR.
Growth in the right pulmonary artery is shown Figure 5
Growth in the right pulmonary artery is shown.Journal of Cardiovascular Magnetic Resonance 2008, 10:34 http://www.jcmr-online.com/content/10/1/34
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coarctation by CMR was thought not to have a significant
gradient by Doppler, and two unsedated patients did not
have adequate arch views to determine the presence of
coarctation by echocardiography.
Those patients not having a diagnosis of recurrent coarc-
tation had a right ventricular ejection fraction by CMR of
48 +/- 8% as compared to those with recurrent coarctation
their ejection fraction was 41 +/- 12% (p = NS).
Discussion
In this cohort of patients, CMR demonstrates an impor-
tant role in the detection of surgical issues complicating
the Norwood procedure with Sano modification. It was
able to define pulmonary artery stenosis with 100% sensi-
tivity and specificity, and has already been proven to be
instrumental in the evaluation of right ventricular func-
tion and aortic coarctation.
Pulmonary artery growth in this cohort of infants with
hypoplastic left heart syndrome after the Norwood proce-
dure with Sano modification was asymmetric, with greater
growth in the left pulmonary than the right. This asymme-
try of growth may be related to both the direction of the
flow from the right ventricle-to-pulmonary artery conduit,
which is preferential to the left pulmonary artery, and that
the right pulmonary artery must then pass under the
reconstructed aortic arch. This is in contrast to the stand-
ard Norwood palliation, which involves a modified Bla-
lock Taussig shunt, which frequently comes off of the
right-sided innominate artery and inserts onto the right
pulmonary artery. Previous work has shown asymmetric
growth of the pulmonary arteries after the right-sided
modified Blalock Taussig shunt, with the right pulmonary
artery larger than the left [19]. In either type of surgical
shunt, pulmonary artery asymmetry of growth may have
important late implications which have not been yet
defined.
For diagnosing recurrent or persistent coarctation of the
aorta, the CMR has been described as highly sensitive and
specific [12,20]. However, in 1 patient, the CMR incor-
rectly gave a suspicion of a coarctation, and in that patient
the clinical diagnosis was confounded by femoral arterial
occlusion. The patient had been referred for early cardiac
catheterization, which determined no gradient across the
aortic arch which was widely patent on angiography. Ret-
rospective review found a surgical clip casting an artifact
obscuring the aortic isthmus. It is possible that the use of
a phase contrast velocity encoding sequence through the
area of concern for coarctation may be useful in clarifying
this. Therefore, we believe that in the absence of such
imaging artifacts, CMR has an excellent ability to define
the pulmonary artery and aortic anatomy after the Nor-
wood procedure with Sano modification. However, in our
patient series, there was one patient incorrectly diagnosed
with coarctation by CMR. In that patient, an aortic lumi-
nal narrowing was seen on CMR. Since cuff blood pres-
sures and Doppler echocardiography demonstrated no
gradient across the coarctation site, this was felt to be
hemodynamically insignificant. This is likely related to
the observation that not all anatomic narrowings will pro-
duce significant hemodynamic obstructions, which may
be ameliorated by vessel wall compliance and presence of
collateral vessels.
In this cohort of patients, in which the single ventricle is
of right ventricular morphology and in which a ven-
triculotomy was performed, there was a significant
depression of systolic function, as measured by serial
study. In addition, out of 26 initial hospital survivors, 2
subsequently underwent cardiac transplantation with
another currently being listed. The indication in all 3 such
patients was symptomatic heart failure. It is possible that
the ventriculotomy plays a role in the development of late
ventricular dysfunction, as has been noted in other centers
[21]. It is also possible that recurrence of coarctation, with
its attendant increased afterload on the right ventricle,
may contribute to ventricular dysfunction. In our cohort
of patients, we found a non-significant trend of increased
ventricular dysfunction in the group with recurrent coarc-
tation. Importantly, we took an approach of early percuta-
neous intervention to any new diagnosis of recurrent
coarctation, on the assumption that the afterload reduc-
tion was important in these patients' management.
Both the survival to discharge and the interstage mortality
in this cohort of patients following the Norwood proce-
dure with Sano modification were similar to other reports
in the current era[5,8,10,22,23], and has been associated
with improved peri-operative hemodynamic stability[9].
However, it may be that this is a trade-off for later ven-
tricular dysfunction.
Limitations of the present study include the different
imaging modalities to evaluate right ventricular, pulmo-
nary artery, and aortic anatomy and function. However,
previous work has demonstrated excellent correlation
between CMR and cardiac catheterization for right ven-
tricular volumes and function[24,25], for pulmonary
artery anatomy[26], and for coarctation evaluation[27].
Conclusion
Development of significant pulmonary artery stenosis,
coarctation, and right ventricular dysfunction occurs in a
portion of patients undergoing the Norwood palliation
with Sano modification for hypoplastic left heart syn-
drome. Cardiovascular magnetic resonance is instrumen-
tal in surveillance for such complications.Publish with BioMed Central    and   every 
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